State Street
JBIO

State Street’s Jade Biosciences JBIO Stock Holding History

State Street’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.9M Buy
2,335,285
+1,679,595
+256% +$35M ﹤0.01% 1822
2026
Q1 		$9.21M Buy
655,690
+12,769
+2% +$185K ﹤0.01% 2659
2025
Q4 		$9.92M Buy
642,921
+143,634
+29% +$1.68M ﹤0.01% 2656
2025
Q3 		$4.31M Buy
499,287
+180,516
+57% +$1.48M ﹤0.01% 3049
2025
Q2 		$3.18M Buy
318,771
+308,241
+2,927% +$10.5M ﹤0.01% 3131
2025
Q1 		$925K Sell
10,530
-195
-2% -$17.1K ﹤0.01% 3445
2024
Q4 		$995K Buy
10,725
+226
+2% +$19.5K ﹤0.01% 3491
2024
Q3 		$768K Buy
10,499
+751
+8% +$48.4K ﹤0.01% 3523
2024
Q2 		$566K Buy
9,748
+3,177
+48% +$2.11M ﹤0.01% 3552
2024
Q1 		$6.8M Buy
6,571
+456
+7% +$348K ﹤0.01% 2791
2023
Q4 		$4.84M Buy
6,115
+929
+18% +$473K ﹤0.01% 2956
2023
Q3 		$2.46M Sell
5,186
-210
-4% -$114K ﹤0.01% 3239
2023
Q2 		$3.24M Buy
5,396
+122
+2% +$78K ﹤0.01% 3198
2023
Q1 		$3.72M Sell
5,274
-217
-4% -$180K ﹤0.01% 3104
2022
Q4 		$5.63M Buy
5,491
+543
+11% +$394K ﹤0.01% 2990
2022
Q3 		$2.87M Sell
4,948
-154
-3% -$103K ﹤0.01% 3303
2022
Q2 		$2.79M Buy
5,102
+301
+6% +$144K ﹤0.01% 3367
2022
Q1 		$3.08M Buy
4,801
+395
+9% +$153K ﹤0.01% 3402
2021
Q4 		$1.82M Buy
4,406
+810
+23% +$410K ﹤0.01% 3666
2021
Q3 		$2.64M Buy
+3,596
New +$2.01M ﹤0.01% 3536

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street's JBIO Position: Q2 2026 in Review

State Street increased its Jade Biosciences (JBIO) stake by 256% in Q2 2026, buying an estimated $35M and bringing the position to 2,335,285 shares worth $51.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

State Street first reported a position in JBIO in Q3 2021 and has held it in 20 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • State Street held 2,335,285 shares of Jade Biosciences worth $51.9M as of Q2 2026.
  • State Street bought 1,679,595 Jade Biosciences shares in Q2 2026, an estimated $35M.
  • Jade Biosciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1822 holding.
  • State Street first reported a position in Jade Biosciences in Q3 2021 and has held it in 20 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.